Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals’ generic oxycodone/acetaminophen product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)